riserr
2021-12-09
Up up all the way
Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA批准Xaciato>DARE后Dare Bioscience股价上涨</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":602119706,"tweetId":"602119706","gmtCreate":1638980146783,"gmtModify":1638980146783,"author":{"id":4087297988376160,"idStr":"4087297988376160","authorId":4087297988376160,"authorIdStr":"4087297988376160","name":"riserr","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Up up all the way</p></body></html>","htmlText":"<html><head></head><body><p>Up up all the way</p></body></html>","text":"Up up all the way","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/602119706","repostId":1196789631,"repostType":2,"repost":{"id":"1196789631","kind":"news","pubTimestamp":1638919795,"share":"https://www.laohu8.com/m/news/1196789631?lang=zh_CN&edition=full","pubTime":"2021-12-08 07:29","market":"us","language":"en","title":"Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA批准Xaciato>DARE后Dare Bioscience股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196789631","media":"Marketwatch","summary":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and ","content":"<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.</p><p><blockquote>在美国食品和药物管理局批准Xaciato用于治疗12岁及以上女性细菌性阴道病后，Dare Bioscience Inc.的股价周二盘后交易中上涨超过35%。</blockquote></p><p> The approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.</p><p><blockquote>此次批准标志着FDA首次为这家圣地亚哥公司开绿灯，该公司表示正在就战略合作伙伴关系和其他活动进行谈判，旨在支持该药物明年在美国的强劲市场推出。</blockquote></p><p> Dare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.</p><p><blockquote>Dare此前获得了FDA对Xaciato的合格传染病产品指定，该指定将该产品的三年市场独占权延长了五年。</blockquote></p><p> Dare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.</p><p><blockquote>Dare股价周二收于2.12美元，最近在盘后交易中易手至2.87美元，上涨35.3%。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA批准Xaciato>DARE后Dare Bioscience股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA批准Xaciato>DARE后Dare Bioscience股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Marketwatch</strong><span class=\"h-time small\">2021-12-08 07:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.</p><p><blockquote>在美国食品和药物管理局批准Xaciato用于治疗12岁及以上女性细菌性阴道病后，Dare Bioscience Inc.的股价周二盘后交易中上涨超过35%。</blockquote></p><p> The approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.</p><p><blockquote>此次批准标志着FDA首次为这家圣地亚哥公司开绿灯，该公司表示正在就战略合作伙伴关系和其他活动进行谈判，旨在支持该药物明年在美国的强劲市场推出。</blockquote></p><p> Dare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.</p><p><blockquote>Dare此前获得了FDA对Xaciato的合格传染病产品指定，该指定将该产品的三年市场独占权延长了五年。</blockquote></p><p> Dare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.</p><p><blockquote>Dare股价周二收于2.12美元，最近在盘后交易中易手至2.87美元，上涨35.3%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing\">Marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DARE":"Dare Bioscience"},"source_url":"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1196789631","content_text":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.\nThe approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.\nDare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.\nDare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.","news_type":1,"symbols_score_info":{"DARE":0.9}},"isVote":1,"tweetType":1,"viewCount":1244,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":13,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/602119706"}
精彩评论